FDA Import Refusal 112-4781875-5/4/1 — InvaGen Pharmaceuticals, Inc.
The FDA refused shipment 112-4781875-5/4/1 from InvaGen Pharmaceuticals, Inc. (United States) on November 21, 2011. The refused product falls under Drugs and Biologics — GEMFIBROZIL (ANTI-CHOLESTEREMIC). Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- November 21, 2011
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61JCB11 GEMFIBROZIL (ANTI-CHOLESTEREMIC)
- Charges
- 118,75